Results 31 to 40 of about 77,778 (298)
microRNAs in viral acute respiratory infections: immune regulation, biomarkers, therapy, and vaccines [PDF]
ExRNA, 2019 MicroRNAs (miRNAs) are single-stranded RNAs of 17–24 nt. These molecules regulate gene expression at the post-transcriptional level and are differentially expressed in viral acute respiratory infections (ARIs), which are responsible for high morbidity ...
Stephen A. Leon-Icaza +2 more
doaj +1 more source
RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
Viruses, 2022 It is important to understand the features affecting virus replication, fitness, and transmissibility as they contribute to the outcome of infection and affect disease intervention approaches. Respiratory syncytial virus (RSV) is a major contributor to respiratory disease, particularly in the infant and elderly populations.
Harrison C. Bergeron, Ralph A. Tripp
openaire +3 more sources
Health Science Reports, 2018 A study of infant bronchiolitis–coded episodes described the proportion of events attributable to respiratory syncytial virus (RSV) and demonstrated that episodes occurring during the peak months of winter viral season, among younger infants, and among those with higher levels of care, were more likely to be attributable to RSV.
openaire +2 more sources
Journal of Behçet Uz Children's Hospital, 2021 Objective: The risk of severe respiratory syncytial virus (RSV) infection with significant morbidity and mortality is greatest in patients with hemodynamically significant congenital heart disease (hs-CHD). The humanized monoclonal antibody, palivizumab,
Ali Orgun +2 more
doaj +1 more source
Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol [PDF]
, 2021 BACKGROUND: Respiratory syncytial virus (RSV) infection is an important cause of hospitalization and death in young children. The majority of deaths (99%) occur in low- and lower-middle-income countries (LMICs).
RSV GOLD III—ICU Network study group
core
Drug, Healthcare and Patient Safety, 2023 Shaun O’Hagan,1,2 Niamh Galway,3 Michael D Shields,3,4 Peter Mallett,1,4 Helen E Groves1,2 1Paediatric Infectious Diseases, Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland; 2Wellcome-Wolfson Institute for Experimental Medicine, Queen ...
O'Hagan S +4 more
doaj
Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding [PDF]
, 2015 RSV is the most important viral cause of pneumonia and bronchiolitis in children worldwide and has been associated with significant disease burden. With the renewed interest in RSV vaccines, we provide realistic estimates on duration, and influencing ...
Agoti, Charles N. +7 more
core +1 more source
A multifaceted approach to RSV vaccination
Human Vaccines & Immunotherapeutics, 2018 Respiratory Syncytial Virus (RSV) is the leading cause of pneumonia and bronchiolitis in infants, resulting in significant morbidity and mortality worldwide.
Jorge C. G. Blanco +3 more
doaj +1 more source
The Nurse Practitioner, 2018 Abstract: Respiratory syncytial virus (RSV) is a common viral infection affecting many children in the United States. This seasonal virus is the leading cause of hospitalization of infants and neonates. This article reviews the current recommendations for diagnostic testing, treatment options, and prevention of RSV.
openaire +3 more sources
, 2020 Additional hamsters in groups of 6 were inoculated as described in the legend to Fig 5 with the indicated HPIV3-RSV-F vectors, or the B/HPIV3 vector GS/DS-Cav1/B3TMCT, or wt RSV. (A, B) Serum RSV-neutralizing antibody titers.
Sonja Surman (185609) +8 more
core +1 more source